Societal Burden of Clinically Anxious Youth Referred for Treatment: A Cost-of-illness Study by Bodden, Denise H. M. et al.
Societal Burden of Clinically Anxious Youth Referred
for Treatment: A Cost-of-illness Study
Denise H. M. Bodden & Carmen D. Dirksen & Susan M. Bögels
Published online: 23 January 2008
# The Author(s) 2007
Abstract A prevalence-based cost-of-illness study using a
societal perspective was conducted to investigate the cost-
of-illness in clinically anxious youth aged 8–18 in The
Netherlands. Discriminant validity of the cost diary used
was obtained by comparing costs of families with an
anxious child (n=118) to costs of families from the general
population (n=41). To examine the convergent validity,
bottom-up acquired costs derived from cost diaries were
compared to top-down acquired costs obtained from
national registrations. Bottom-up acquired costs measured
by means of cost diaries amounted to €2,748 per family of a
clinically referred anxious child per annum. Societal costs
of families with clinically anxious children were almost 21
times as high compared to families from the general popu-
lation. With respect to convergent validity, total health care
costs using the bottom-up approach from clinically anxious
children were quite comparable to those of top-down data
of anxious children, although costs within the subcategories
differed considerably. Clinical anxiety disorders in child-
hood cost the Dutch society more than 20 million euros a
year. Based on results of discriminate and convergent
validity, the cost diary seems a valid method in establishing
cost-of-illness in childhood anxiety disorders.
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Anxiety disorders are among the most common childhood
mental disorders. Prevalence rates for children with anxiety
disorders vary considerably in the international literature
from 1.8 (Anderson et al. 1987) to 25% (Kessler et al.
1994). In The Netherlands, a 6-month prevalence rate of
23.5% for anxiety disorders was found in 13- to 18-year-old
adolescents. When impairment in daily functioning is taken
into consideration, Klein and Pine (2002) estimated the
prevalence rate to be between 5 and 10%. A Dutch study
revealed that the prevalence rate of severely interfering
child anxiety disorders is 9.7% (Verhulst et al. 1997). The
yearly prevalence rate of children with a mental disorder
seeking treatment in mental health care ranges from 1.6
(Sytema and Koopmans 1998) to 8.1% (Leaf et al. 1996). In
The Netherlands, merely 3.5% of 4- to 18-year-old children
with a mental disorder had been referred yearly to mental
health care for treatment (Verhulst and van der Ende 1997).
This latter percentage resembles the 4% of Dutch people
with anxiety disorders who are referred for further treatment
by their general practitioner (van Wieren et al. 2007).
With respect to costs, the total costs for anxiety disorders
in adults were highest of all mental illnesses, namely
46.6 billion dollars, accounting for 31.5% of total expendi-
tures for mental health in 1990 in the USA (Dupont et al.
1996). Greenberg and colleagues (1999) estimated the
annual costs of anxiety disorders in adults to be 63.1 billion
dollars in the USA in 1998 by extrapolating the costs of
1990. Besides direct costs of treating anxiety disorders,
indirect costs due to impaired social functioning, such as
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adults with anxiety disorders (Leon et al. 1995). In The
Netherlands, health care costs of anxiety disorders across
all ages were 180 million euro in 1999, accounting for
0.5% of the health care budget. More specifically, health
care costs due to anxiety disorders in 1- to 24-year-old
children and young adults amounted to 21.6 million euros
(Polder et al. 2002).
An analysis to measure the magnitude of costs related to
illness is called a cost-of-illness study and involves an
estimation of the total economic burden which an illness
imposes on society. The main objective of a cost-of-illness
study is to translate the burden on society into monetary
costs. Typically in a cost-of-illness study all costs associ-
ated with a particular illness are identified and measured,
including health care costs, patient and family costs and
costs occurring in other sectors. The results of a cost-
of-illness study can be used to gain insight in how much
society is spending on a disease, and how much potentially
can be saved if effective treatment is offered. Also, it
identifies the different cost categories and the size of the
contribution of each sector in society. The information
coming from cost-of-illness studies can be helpful in setting
priorities for health care efficiency research (Ament and
Evers 1993; Polder et al. 2002; Rice and Miller 1995).
Essentially there are two approaches to establish the
cost-of-illness, namely the bottom-up and the top-down
approach. The bottom-up approach acquires data on the
patient level by means of registrations or self-report
measures. Self-report measures contain retrospective cost
questionnaires, retrospective cost interviews or prospective
cost diaries (Bruijnzeels et al. 1998a; Sleed et al. 2005).
The bottom-up approach enables one to capture resource
use that is likely to vary from patient to patient and may not
be easily extracted from existing data sources. Multiplying
the costs per patient by the national prevalence rate results
in the total cost-of-illness for a particular patient group. An
advantage of the bottom-up approach is that detailed data
can be obtained regarding costs outside the health care sec-
tor, such as costs due to productivity losses, out-of-pocket
costs, costs of informal care, and costs due to absence from
school. A disadvantage of this method may be that the
sample of patients used for the cost-of-illness calculations is
not representative of the entire patient group, for example
due to strict inclusion and exclusion criteria (Oostenbrink
et al. 2004; Polder et al. 2002). The top-down approach
involves gathering data from existing (national) registra-
tions on total costs of a service category such as hospital
care, and dividing these costs by an appropriate unit, such
as a patient group using the service category, mostly per
year if appropriate. While there are benefits using this
approach such as being less resource intensive, this cal-
culation may also prove to be less accurate (Byford et al.
2003). Furthermore, when using a top-down approach it is
difficult, if not impossible, to obtain costs outside the health
care sector (Oostenbrink et al. 2004; Polder et al. 2002).
Another important distinction in cost-of-illness studies is
that costs can be determined from a prevalence-based or
incidence-based perspective. In a prevalence-based ap-
proach, the costs of a disorder are determined for a fixed
period of time, as a result of the prevalence of the disorder
(number of cases of a disorder at a specific time). This
period is called the base period and most often studies
investigate the annual economic burden, thus based on a
year (Ament and Evers 1993; Rice and Miller 1995). A
disadvantage of the prevalence-based approach is that it
may be difficult to isolate potential differences in costs by
stage or duration of the disorder (Greenberg et al. 1999).
The incidence based approach estimates the lifetime costs
of an illness from its onset, thus costs are assigned to the
year in which the illness begins (Ament and Evers 1993;
Rice and Miller 1995). Incidence based studies can isolate
the differences in costs by stage or duration of the disease.
However, a disadvantage of using this approach is that
follow up research is required.
In this article, a prevalence-based cost-of-illness analysis
was performed in 8- to 18-year-old children and adoles-
cents with anxiety disorders, who were referred to treat-
ment. The primary aim of this study was to establish the
societal costs of illness in families with a clinically anxious
child, using the bottom-up approach by means of a pro-
spective cost diary. A secondary aim of this study was to
investigate the discriminative validity of the prospective
cost diary by comparing the costs related to anxiety,
psychological, physical and other problems in families with
a clinically anxious child to the same costs in families from
the general population. The third aim of this study was to
establish convergent validity by comparing bottom-up
acquired health care costs obtained with the cost diaries of
the clinically anxious children with top-down acquired
health care costs of children with a primary diagnosis of
anxiety disorder.
Materials and Methods
Participants
For the cost-of-illness study and the discriminative validity
study, participants were clinically anxious children and
adolescents from the general population, respectively. The
clinically anxious group consisted of 118 families with a
child referred for community mental health treatment
because of anxiety, and participated in a multi-centre ran-
domized clinical trial comparing family Cognitive Behav-
ioural Therapy (CBT) with individual CBT (Bodden et al.
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March 2002 to November 2005, inclusion ended in March
2004. Inclusion criteria were (1) age 8–18, (2) a primary
anxiety disorder (except for obsessive-compulsive and post-
traumatic stress disorder), (3) IQ≥80, and (4) at least one
parent willing to participate. Children were excluded if
suffering from (1) substance abuse, (2) current suicide
attempts, (2) psychoses, (3) autism-spectrum disorders, or
(4) untreated Attention Deficit Hyperactivity Disorder
(ADHD). Children using medication for their anxiety were
only included if dosage was kept constant during treatment
andfollow-up.There were74girls(63%)and44boys (37%),
range 8–17 years (M=12.4, SD=2.6). Most were Caucasian
(n=117, 99%) and 53 (45%) attended primary education.
The remaining 65 (55%) attended secondary education.
According to the compound diagnosis on the Anxiety
Disorders Interview Schedule (ADIS; Silverman and
Albano 1996), the mean number of diagnosis per child
was 2.9 (SD=1.7), whereas the mean severity level of the
primary diagnosis was 7.1 (SD=1.0). Furthermore, primary
anxiety diagnoses consisted of social phobia (n=37, 31%),
separation anxiety (n=32, 27%), generalized anxiety
disorder (n=21, 18%), specific phobia (n=20, 17%), and
panic disorder with or without agoraphobia (n=8, 7%). Of
the 118 children, 94 (80%) had one or more comorbid
anxiety disorder(s); separation anxiety disorder (n=20,
17%), social phobia (n=43, 36%), specific phobia (n=51,
43%), panic disorder (n=20, 17%), generalized anxiety
disorder (n=42, 36%), obsessive-compulsive disorder (n=
5, 4%), and post-traumatic stress disorder (n=7, 6%).
Moreover, 29 (25%) had comorbid dysthymic disorder or
depression, 9 (8%) ADHD, 2 (2%) conduct disorder, and 1
(1%) oppositional defiant disorder.
The sample from the general population consisted of a
group of 41 families who were recruited via advertisements.
Children of these families were comparable to children
from the clinically anxious group based on gender, χ
2 (1)=
19, p>0.1, age, F (1, 154)=0.0, p>0.1, and educational
level, F (1, 154)=2.6, p>0.1. There were 27 girls (66%)
and 14 boys (34%), range 8–17 years (M=12.5, SD=2.5).
Most were Caucasian (n=40, 98%) and 16 (39%) attended
primary school. The remaining 25 (61%) attended second-
ary education. According to the compound diagnosis on the
ADIS, the prevalence of anxiety disorders in this sample
was 12% (n=5) and 2.4% (n=1) for ADHD, closely
resembling Dutch prevalence of anxiety disorders and
ADHD, respectively 9.7% and 2.3% (Verhulst et al.
1997). The primary anxiety diagnoses consisted of social
phobia (n=1, 20%) and specific phobia (n=4, 80%) with a
mean severity level of 4.8 (SD=0.8). The overrepresenta-
tion of simple phobia and the relatively low severity rates
of the anxiety disorders in the control group also support
the “normality” of the control children.
All children and parents received and signed a written
informed consent after receiving oral and written informa-
tion on the study. Clinically anxious children, their siblings
and parents were assessed before treatment and families
from the general population were only measured once.
Furthermore, all family members had to fill in a battery of
questionnaires, including a prospective cost diary.
Anxiety Disorders Interview Schedule
Children’s diagnostic status was assessed using the Dutch
ADIS-C/P (Siebelink and Treffers 2001), which is a semi-
structured diagnostic interview measuring anxiety disorders
and other DSM-IV childhood psychopathology. The sever-
ity score consists of impairment in daily functioning per
diagnosis and ranges from 0 to 8, 4 indicating a clinical
diagnosis. Based on criteria, child and parents ratings are
combined in a compound summary. The ADIS-C/P pos-
sesses good psychometric properties (Silverman et al. 2001).
In our study, the total inter-rater agreement for all ADIS
diagnoses (kappa) was averaged and was 0.89 for the ADIS-
C and 0.83 for the ADIS-P. The mean inter-rater agreement
for the severity score was calculated with correlations and
was 0.98 for the ADIS-C and 0.83 for the ADIS-P.
Prospective Cost Diary
A cost diary was used to determine the resources used
(Freer 1980; Goossens et al. 2000) in both the cost-
of-illness study as well as in the discriminative validity
study. Cost dairies were completed prospectively by one of
the parents and covered a period of 2 weeks. Families of
clinically anxious children received the cost diary 2 weeks
before treatment and the sample of families from the
general population received the same cost diary during
their one time assessment. Each cost diary was presented in
a booklet form with instructions and an example diary. The
cost diary was designed such that all costs which are
potentially relevant to society were captured, including
health care costs, patient and family costs and costs in other
sectors. Parents recorded the following resource use: visits
to psychologist or psychotherapist, visits to the general
practitioner, outpatient consultations at the hospital, medi-
cation, day treatment, costs of paid house help, children’s
day care, after school care, informal care, productivity
losses due to absence of work by the parents, loss of
household activities or voluntary work, loss of leisure time,
absence from school of the child, and out-of-pocket costs.
Informal care means that persons near the family, such as
relatives, friends, or neighbors, take care of the family and
possibly take over some domestic tasks. Out-of-pocket
costs are actual expenses made by the family (and are
therefore paid ‘out of the pocket’), and include for example
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cation and own monetary contributions for health care
services which are not fully reimbursed by health insurance
companies. Also, parents recorded the name of the family
member for whom the resource use was applicable (child,
sibling, mother or father), as well as the reason for the
resource use by that family member. For analysis, the
reported reasons were grouped into (1) due to anxiety, (2)
due to psychological problems, (3) due to physical prob-
lems, and (4) due to other reasons.
Unit Prices
Costs were calculated by multiplying the resources used,
obtained with the prospective cost diaries, by the unit price
of each resource. Costs were calculated at 2003 euros (1€=
0.087$, July 30th 2003). It should be noted that, whenever
possible, unit prices and not transfer payments such as
charges, reimbursements or patient bills were used to value
health care resource use. Money transfers may bear little
relation to actual resource consumption as a result of (local)
budgeting agreements and political negotiations (Finkler
1982). For example, in The Netherlands hospitals receive
an annual budget. As a consequence, the reimbursement of
a day of hospitalization (which is the amount a hospital
charges to a health care insurance company) may vary from
year to year as it is used as a balancing item for a budget
overdrawing. The key point is that the amount that ex-
changes hands between providers, third-party payers and
patients are not necessarily a good measure of resources
used. Therefore, for the valuation of resource consumption
in health care, mostly actual unit prices are used, which are
obtained by performing unit price calculations. Unit prices
consist of personnel, material and capacity costs, as well as
costs of housing and overhead.
Almost all unit prices were obtained by using published
Dutch guideline prices (Oostenbrink et al. 2004). However,
medication prices were obtained from the Medication and
Aid Information Project database on the Internet (Board of
Health Insurances 2005) and were based on the Daily
Defined Dosage (DDD), which indicates the mean medica-
tion usage per person a day with claw back and value added
tax (VAT) (20%). An average unit price was calculated for
medication for anxiety problems and medication for
psychological problems. As actual unit prices for day
treatment and institutionalization were not available, the
prices were derived from the average of actual reimburse-
ments (Board Tariff Rates Health Care and Care Authority
2005). It should be noted that the unit price of informal
care, loss of leisure time, voluntary work and domestic
activities was based on a ‘shadow price’ as stated in the
Dutch guideline (Oostenbrink et al. 2004). A key charac-
teristic of informal care, leisure time, voluntary work and
domestic activities is that it is unpaid. So, these activities by
definition do not have an official unit price, since no actual
payments take place. If an official unit price is not
available, resource use should be valued against a ‘shadow
price’. This means that informal care, loss of leisure time,
voluntary work and domestic activities were valued against
the wage rate per hour of a housekeeper. To determine the
costs associated with absence from school, actual annual
tuition, which consists of a contribution by parents and a
state-subsidy per child (National Institute of Budget
information 2005), was divided by the total annual hours
at school according to the standard, resulting in a price per
hour of school attendance. As the larger part of school costs
is fixed, such as the costs of housing, (teaching) personnel
and school materials, a child missing school does not result
in actual savings. Therefore, the actual costs per hour of
school attendance were used to value an hour of school
absence. Productivity costs of the parents due to absence
from paid work were calculated by means of the friction
cost method, based on a mean added value of the Dutch
working population (Oostenbrink et al. 2004). This method
only takes into account production losses confined to the
period needed (usually 90 days) to replace a sick employee.
Cost-of-illness
The primary aim of this study was to calculate the societal
burden of illness of families of clinically anxious youth in
The Netherlands. The cost-of-illness study was performed
from a societal perspective and included direct health care
costs, direct non-health care costs, indirect costs and out-
of-pocket costs.
The costs per family over a period of 2 weeks were ex-
trapolated to a period of 1 year (i.e. multiplied by 26) under
the assumption that data obtained with the cost diaries were
representative for that period (Goossens et al. 2000).
Subsequently, the annual costs per family were multiplied
by the Dutch prevalence figure for anxiety disorders, which
is 9.7% (Verhulst et al. 1997) and the percentage of referred
children of 3.5% (Verhulst and van der Ende 1997), which
results in a multiplication factor of 0.34%, to calculate the
total annual societal cost-of-illness of families of clinically
anxious children referred for treatment. It was assumed that
the percentage of referred children with a mental disorder
(3.5%) could be attributed to anxiety disorders as well.
F u r t h e r m o r e ,al o wa n dh i g he s t i m a t i o no ft h ec o s t -
of-illness was calculated. The low multiplication factor of
0.08% was derived by multiplying the low prevalence rate
of children with a mental disorder seeking treatment in
mental health care of 1.6% with the low prevalence rate of
impairment in functioning of 5% (i.e. 1.6×5%). The high
multiplication factor of 0.81% was derived by taking the
high prevalence rate of children with a mental disorder
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multiply this with the high prevalence rate with impairment
in functioning of 10% (i.e. 8.1×10%).
Discriminative Validity
To determine the discriminative validity of the prospective
cost diary, the societal costs of the 118 families of anxious
children were compared to the societal costs of 41 families
from the general population. For this purpose, all costs
related to the child, irrespective of reason, were taken into
account (i.e. psychological, physical or other). For both
groups, the costs per family over a period of 2 weeks were
extrapolated to a period of 1 year to obtain the annual costs
per child for both groups. It was hypothesized that costs for
anxiety problems were higher in the clinically anxious
group compared to the general population but comparable
between the two groups for psychological, physical and
other problems.
Convergent Validity
To establish convergent validity, health care costs per child
per year obtained with the prospective cost diaries of 118
clinically anxious children were compared with the health
care costs of children with a primary diagnosis of anxiety
disorder, according to top-down registrations. For this
comparison, only health-care costs due to anxiety of the
child were considered, because the costs obtained with the
top-down registration applied to children with a primary
diagnosis of anxiety disorder and only consisted of costs
related to the health care sector.
The top-down data were obtained from a generic cost
study based on national registrations (Polder et al. 2002). In
this study, the total costs of health care in 1999 were
assigned to diagnosis groups based on actual delivered care,
according to distribution codes which are chosen in such a
way that they represent equal units of care. These dis-
tribution codes are adjusted to the best available data about
the care usage (for more details see Polder et al. 2002). This
was done for each of the 21 health care sectors including
the mental health care sector. Diagnosis groups were based
on the International Statistical Classification of Diseases,
injuries and causes of death (ICD-9; World Health
Organization 1977). The ICD-9 is divided into 17 chapters,
including chapter V, mental and behavioural disorders.
Furthermore, a more intricate classification is used, by
itemizing the chapters into 96 specific diagnosis groups,
including anxiety disorders. All anxiety disorders are taken
into account (ICD-9 300.0-3 and 300.5-9) (World Health
Organization 1977).
The top-down data could not be compared directly to the
group of 8–18 year old children included in the bottom-up
cost-of-illness analysis, because costs were presented for
the age groups 5- to 9-, 10- to 14- and 15- to 19-year-olds.
Therefore, the assumption was made that costs were equally
distributed within the age groups, so the corresponding ages
(8–18) could be filtered out by averaging the costs and
multiplying them by each age year (Polder et al. 2002).
Since top-down data were based on costs in 1999, for com-
parison with the bottom-up cost-of-illness approach, costs
were actualized to 2003 euros by using the Consumer Price
Index (CPI; Statistics Netherlands 2005).
Statistical Analysis
Statistical analysis could only be performed on the cost-
of-illness study and on the discriminative validity study,
since top-down data were not available on child level.
Missing items in the cost diaries were handled with the
Missing Value Analysis of SPSS based on the regression
models using available data of the group mean, the
available data of the individual and the pattern of change
of the group. To investigate whether data were normally
distributed, a Kolmogorov–Smirnov test was performed.
Due to highly skewed cost distributions, bootstrap simu-
lations were conducted in order to get insight in significant
differences on subtotal and total costs between families of
clinically anxious children and families from the general
population and the uncertainty surrounding these costs. The
bootstrap method estimates the sampling distribution of a
statistic through 1,000 simulations, based on sampling with
replacement from the original data (Briggs, Wonderling and
Mooney 1997). Bootstrap methods are increasingly being
used for analysis of cost data, as traditional parametric and
nonparametric statistical methods to analyse the difference
in mean costs between groups may be inappropriate when
data are skewed (Barber and Thompson 2000; Desgagné
et al. 1998).
Results
Cost-of-illness
All resources used and costs made related to the anxiety of
the child by families with a clinically anxious child were
summed and averaged for 2 weeks and 1 year (Table 1).
The mean costs per family over 2 weeks were extrapolated
to a year and amounted to €2748 per family with a clini-
cally anxious child. Costs were not normally distributed,
Kolmogorov–Smirnov Z=4.5, p<0.01, and skewed to the
left, indicating that a minority of families (n=25, 21%)
reported costs related to the anxiety of the child. A logistic
regression was performed using families with and without
costs as the dependent variable and age, gender, severity
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method. When comparing families who reported costs to
families who reported no costs, binary logistic regression
revealed only one main effect for age, corrected for gender,
severity and number of diagnoses, Wald (1)=11.4, p<0.01, O.
R.=1.4. No main effect was found for gender, severity or
number of diagnoses, Wald (1)s<0.2, ps>0.1. This indicates
that in families who reported costs related to the child’s
anxiety, the child was older compared to families who
reported no costs, irrespective of gender, severity and number
of diagnoses. The main contributor to costs were costs related
to institutionalized treatment (26% of total costs), day
treatment (23% of total costs), productivity loss of the parents
(23% of total costs) and school absence (17% of total costs).
The total number of Dutch children aged 8–18 in 2003
was computed using data of the Statistics Netherlands
(2005), and resulted in 2,175,382 children. Multiplying this
figure by 0.34% resulted in 7,385 Dutch children with an
anxiety disorder that interferes with daily functioning and
who are referred to treatment. Hence, the annual societal
cost-of-illness accumulated to €2,748×7,385=€20,293,958
for families of clinically anxious children referred for
treatment in the Netherlands. The same calculation was
performed using the low and high multiplication factors.
This resulted in a low estimate of the cost-of-illness of
€4,783,839 and a high estimate of €48,436,370.
Discriminative Validity
The mean total annual societal costs related to anxiety,
psychological, physical and other reasons for families with
Table 1 Mean total resource use, subtotal and total societal costs due to anxiety reasons using a bottom-up approach (n=118)
Costs per unit Total resource
use (2 weeks)
Total costs
(2 weeks)
Total costs
per child
(2 weeks)
Total costs
per child a year
Sum Sum M (SD) M (SD)
Direct health care costs
Psychologist 124/contact
1 0.00 0.00 0.00 0.00
Psychiatrist 76.00/contact
1 0.00 0.00 0.00 0.00
G.P practice 20.20/contact
1 3.00 60.60 0.51 (4.14) 13.35 (108)
G.P. telephone 10.10/contact
1 1.00 10.10 0.09 (0.93) 2.23 (57.98)
Anxiety medication 0.72/ddd
2 14.25 10.26 0.09 (0.50) 2.26 (13.00)
Pharmacists fee 6.45/med.
1 14.25 91.91 0.78 (4.50) 20.28 (117)
Institutionalized treatment 164/day
5 20.00 3,286 27.85 (213) 724 (5,537)
Day treatment 95.87/day
5 30.00 2,876 24.37 (152) 634 (3,940)
Subtotal 6,335 53.69 (261) 1,396 (6,773)
Bootstrapped subtotal 52.78 (24.05) 1,371 (583)
Direct non-health care costs
Paid house keeper 12.70/h
1 2.00 25.44 0.22 (2.34) 5.61 (60.84)
Informal care 8.30/h
1 32.00 269 2.28 (19.04) 59.23 (495)
Subtotal 294 2.50 (19.16) 64.84 (498)
Bootstrapped subtotal 2.43 (1.76) 68.15 (47.59)
Indirect costs
Paid work 34.98/h
1 83.29 2,888 24.48 (154) 636 (4003)
Unpaid work 8.30/h
1 4.00 33.60 0.28 (3.09) 7.40 (80.34)
Loss of leisure time 8.30/h
1 43.00 361 3.06 (16.47) 79.59 (428)
Household work 8.30/h
1 6.50 54.60 0.46 (4.03) 12.03 (105)
School absence 4.37/h
3 474 2,070 17.55 (57.89) 456.20 (1,505)
Subtotal 5,408 45.83 (198) 1,191.64 (5,135)
Bootstrapped subtotal 46.12 (18.22) 1,193.64 (473)
Out-of-pocket costs
Transportation 0.16/km
1 126 20.20 0.17 (1.41) 4.42 (36.66)
Own contribution alternative treatment 350 2.97 (32.22) 77.12 (838)
Own contribution medication not prescribed 63.30 0.54 (5.83) 13.95 (152)
Subtotal 434 3.67 (38.22) 95.52 (994)
Bootstrapped subtotal 3.86 (36.48) 97.52 (94.08)
Total costs 12,471 106 (340) 2,748 (8,841)
Bootstrapped total costs 104 (32.45) 2,749 (815)
1Source of volume price: Oostenbrink et al. 2004,
2Gip databank,
3Nibud,
4Cost diary,
5Actual costs
492 J Abnorm Child Psychol (2008) 36:487–497a clinically anxious child and families from the general
population are presented in Table 2. In the clinically
anxious group, costs due to anxiety reasons were highest
(89% of total costs), followed by costs due to physical
reasons (6% of total costs), costs due to other reasons (3%
of total costs) and psychological reasons (3% of total costs).
The total annual costs of families with clinically anxious
children due to anxiety problems, psychological problems,
physical problems and other amounted to a mean of €3,084
(SD=8,945) per child.
Costs of families from the general population were
highest for physical reasons (95% of total costs). A small
proportion of costs was assigned to psychological reasons
(5% of total costs) and other reasons (0.2% of total costs).
Despite the fact that five children in the control group met
criteria for an anxiety disorder, families reported no costs
for anxiety reasons. The total annual costs obtained from
families of the general population amounted to a mean of
€148 (SD=523) per family.
Costs in both groups were not normally distributed
(Kolmogorov–Smirnov Z>1.6, p<0.05). The bootstrapped
results indicated that total societal costs were significantly
higher in families with clinically anxious children com-
pared to families from the general population. Subdividing
the costs into reason showed significant higher costs related
to anxiety and other reasons in families with a clinically
anxious child compared to families from the general
population. Costs related to psychological reasons were
Table 2 Subtotal and total costs for clinically anxious children and children from the general population per year using a bottom-up approach (n=118)
Anxiety reason Psychological reason Physical reason Other reason Total a year
Cl. anx. Gen. Cl. anx. Gen. Cl. anx. Gen. Cl. anx. Gen. Cl. anx. Gen.
Direct health care costs
Psychologist/psychiatrist 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
G.P practice 13.35 0.00 4.45 0.00 13.35 0.00 0.00 0.00 28.86 0.00
G.P. telephone 2.23 0.00 2.23 0.00 4.45 0.00 0.00 0.00 8.84 0.00
Hospital visit 0.00 0.00 0.00 0.00 34.37 98.80 17.19 0.00 51.48 98.80
Emergence visit hospital 0.00 0.00 0.00 0.00 30.63 0.00 0.00 0.00 30.68 0.00
Medication 2.26 0.00 2.29 0.00 6.80 4.68 0.22 0.00 11.70 4.68
Pharmacist fee 20.25 0.00 18.48 0.00 29.84 20.54 1.42 0.00 69.94 20.54
Day treatment 634 0.00 0.00 0.00 0.00 0.00 0.00 0.00 634 0.00
Institutionalized treatment 724 0.00 0.00 0.00 0.00 0.00 0.00 0.00 724 0.00
Subtotal 1,396 0.00 27.44 0.00 119 124 18.83 0.00 1,559 124
Bootstrapped subtotal 1,521 124
Direct non-health care costs
House keeper 5.61 0.00 0.00 0.00 0.00 0.00 8.41 0.00 14.04 0.00
Informal care 59.23 0.00 0.00 0.00 0.00 0.00 14.81 0.00 74.10 0.00
Subtotal 64.83 0.00 0.00 0.00 0.00 0.00 23.21 0.00 88.05 0.00
Bootstrapped subtotal 87.21 0.00
Indirect costs
Paid work 636 0.00 0.00 0.00 0.00 0.00 7.67 0.00 644 0.00
Unpaid work 7.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.28 0.00
Leisure time loss 79.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 79.56 0.00
Household work 12.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.96 0.00
School absence 456 0.00 51.01 0.00 48.60 0.00 15.88 0.00 572 0.00
Subtotal 1,192 0.00 51.01 0.00 48.60 0.00 23.55 0.00 1,315 0.00
Bootstrapped subtotal 1,305 0.00
Out-of-pocket costs
Transportation 4.45 0.00 0.76 0.00 3.68 0.00 0.85 0.00 9.62 0.00
Alcohol 0.00 0.00 0.00 0.00 0.00 0.00 11.13 0.29 11.18 0.29
Caffeine 0.00 0.00 0.00 0.00 0.50 0.00 0.78 0.00 1.30 0.00
Tobacco 0.00 0.00 0.00 0.00 0.00 0.00 7.40 0.00 7.28 0.00
Own expenses 91.07 0.00 0.00 7.29 1.38 16.49 0.00 0.00 92.56 23.66
Subtotal 95.52 0.00 0.76 7.29 5.55 16.49 20.16 0.29 122 23.92
Bootstrapped subtotal 125 23.89
Total costs 2,748 0.00 79.21 7.29 174 141 85.75 0.29 3,084 148
Bootstrapped total 2,790 0.00 78.44 7.23 173 142 86.99 0.32 3,070 147
Incremental costs (95% CI) −2,790 (−4,530 to −1,336) −71 (−205 to 0) −31 (−199 to 131) −87 (−152 to −33) −2,923 (−4,505 to −1,470)
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clinically anxious child (see Table 2).
Convergent Validity
The total health care costs of 8- to 18-year-old children with
a primary diagnosis of anxiety disorder amounted to
€8,018,000 in 1999 using the top-down approach, which
augmented to €9,075,613 in 2003 when corrected with CPI.
The total number of anxious 8- to 18-year-old children
referred for treatment in 2003 was 7,385 (i.e. 2,175,382×
0.34%). Dividing the total health care costs due to anxiety
in children by this number resulted in €1,229 per anxious
child that was referred (see Table 3).
Direct health care costs derived from the bottom-up
method were used to compare with the top-down approach
and amounted to €1,410 per referred anxious child (see
Table 3). Total health care costs for clinically anxious
children resulted in €10,412,187 with a low estimate of
€2,453,541 and a high estimate of €24,842,036. Although
the overall difference in total health care costs between the
bottom-up and top-down approach per anxious child per
year were about €180 (top-down 13% lower than bottom-
up), the differences in costs per health care sector were
considerably higher. For instance, costs of medical hospital
care were €287 higher using the top-down approach (23%
of total costs) compared to costs obtained with the bottom-
up approach (0% of total costs). On the other hand, mental
health care costs were €573 higher (top-down 42% lower
than bottom-up) using the bottom-up approach (96% of
total costs) compared to the costs obtained with the top-
down approach (64% of total costs).
Discussion
To the authors’ knowledge, this is the first cost-of-illness
study in clinically anxious children referred for treatment.
The aim of this study was threefold. The first aim was to
measure the societal costs of illness in clinically anxious
children and their families, using a bottom-up approach by
means of a prospective cost diary. The second aim was to
investigate the discriminative validity of the prospective
cost diary by comparing the costs of families with a
clinically anxious child to the costs of families from the
general population. The third aim of the study was to es-
tablish convergent validity by comparing bottom-up ac-
quired health care costs of the clinically anxious children
with top-down acquired health care costs of children with a
primary diagnosis of anxiety.
With respect to results regarding cost-of-illness, bottom-
up acquired total societal costs for families of clinically
anxious children referred for treatment amounted to more
than €20 million per year in the Netherlands with a low
estimation of 4.8 and a high estimation of 48 million euros,
which is a quite broad range. Costs amounted to €2,748 per
family with a clinically anxious child per year. These costs
seem relatively low compared to costs of other childhood
psychopathology. Knapp et al. (1999) conducted a pilot
study on ten children aged 4–10 with conduct disorders.
Cost amounted to €22,272 per family per year, which is
about eight times as high as the costs per family with a
clinically anxious child in our study. However, a more
elaborate study (n=80) on 3- to 8-year-old children with
anti-social behaviour (Romeo et al. 2006), reported lower
mean annual total costs, namely €8781 per child, still 3.2
times higher than those of anxious children. In another
study on 11 children with autism spectrum disorders,
societal costs were €51,844 per child per year (Järbrink et
al. 2003), which is 19 times higher than the costs per
anxious child. It should be noted that the prevalence rate for
anxiety is almost four times as high as conduct disorder
(2.6%, Verhulst et al. 1997) and 39 to 44 times higher than
the prevalence rate for autism spectrum disorders (0.22–
0.25%, van der Gaag et al. 1996). Consequently, the
relative costs for society of childhood anxiety disorders,
combining absolute costs with prevalence, are similar to
conduct disorders and higher than those of autism spectrum
disorders.
In line with Knapp et al. (1999), Romeo et al. (2006) and
Järbrink et al. (2003) a large part of the costs in our study
can be attributed to the parents’ productivity loss due to
anxiety disorders of the child (23% of total costs). Knapp et
al. (1999) found that per family with a child with conduct
disorder, the annual costs due to lost employment were
€5,683 (30% of the total costs). Costs to the family related
to extra time spend on household tasks, the need for repairs
Table 3 Direct health care costs, anxiety based per child a year based
on the Bottom-up and top-down approach
Bottom-up
costs
Top-down
costs
A day of hospitalization 0.00 203
Day treatment 0.00 1.84
Polyclinic visit 0.00 42.51
Categorical hospital 0.00 32.71
Remaining 0.00 7.60
Subtotal hospital care 0.00 287
General practitioner 15.58 58.27
Paramedical care 0.00 1.23
Subtotal Primary care 92.70 59.50
Pharmaceutical help 36.49 67.50
Mental health care 1,358 785
Management and care insurances 0.00 29.92
Total costs 1,410 1,229
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child were €4,637, which is 78% of the total costs. Järbrink
et al. (2003) showed that more than 50% of the total costs
of children with an autism spectrum disorder were
attributable to parents and costs related to income loss
were €17,405 (34% of total costs). Our study also found
high costs due to school absenteeism (17% of total costs).
School absence can have long-term economic consequences
such as decreased job opportunities or even unemployment.
Taken together, both productivity costs of parents and
school absence costs of children seem very important and
should be considered in future costing studies. Furthermore,
logistic regression analysis revealed that in families with
costs related to the child’s anxiety, the child was older
compared to families with no costs, irrespective of gender,
severity and number of diagnoses. This is in line with the
finding that top-down health care costs related to anxiety
disorders and health care costs in general increase with age
(Polder et al. 2002). Perhaps older children are more prone
to react against their parents and are more independent,
thereby reducing the influence of parents (Hudson et al.
2002). Itcanbespeculatedthatlessinfluencefromtheparents
may lead to more school absenteeism among older children.
Indeed, 39% of the children aged 18–24 reported school
absenteeism in the last 2 months compared to 13% of the
children aged 12–17 (Statistics Netherlands 2005). Also, the
older child may be more aware of the anxiety complaints,
possibly increasing the costs of mental health care. Future
research should investigate this issue more profoundly.
An additional finding of this study concerns the
difference in measuring costs in children with anxiety
disorders compared to cost-of-illness studies in adults with
anxiety disorders. The main difference of measuring costs
in children with anxiety disorders, as other mental disorders
in children, is that anxiety in the child does not only affect
the child, but also the child’s family. Therefore, the costs
concerning the child’s anxiety should also be measured at
the family level. Although many would argue that the costs
of illness for adults spill over to the family as well, studies on
costs of anxiety disorders in adults usually do not include
family members, especially not their children. So, in future
research it may be interesting to assess the costs of adult
anxietydisordersonafamilylevel aswell. Forexample, they
might be more protective of their children and therefore
increase their children’s health care consumption or more
often let their child miss a day from school. Moreover, in
adult cost-of-illness studies, productivity losses due to
absence of paid work are measured. In children, these kind
of productivity losses do not occur. However, alternatives
suchascostsduetoabsencefromschoolshouldbetakeninto
account, since school participation can be regarded as a
productive activity, and (regular) absence from school may
serve as a proxy for future productivity losses.
With respect to the results regarding discriminative
validity, total costs of families with clinically anxious
children using a bottom-up approach were almost 21 times
higher than costs of families from the general population. In
line with the hypothesis, the difference in costs between
families of clinically anxious children and families from the
general population can largely be subscribed to the
significant difference in anxiety-related costs, showing
good discriminative validity of the cost diary on anxiety
related costs. However, significant differences were also
found on costs due to other reasons. In the prospective cost
diary, the reasons for resource use were recorded based on
subjective judgments by the parents. However, since
anxiety is an internalizing disorder, parents may not always
have been able to interpret children’s symptoms correctly.
Therefore, they may have attributed costs mistakenly to
non-anxiety reasons. For example, parents regularly
reported a baby-sitter for a child old enough to stay on its
own, if the child would not have been anxious. Another
item that was reported as not being related to anxiety was
extra travel expenses for the separation anxious child, who
otherwise could have stayed at home.
With respect to convergent validity, total direct health
care costs related to anxiety were 13% lower using a top-
down approach than using a bottom-up approach, which
seems quite comparable. However, subdividing the costs
into several cost categories showed that costs were
distributed differently among the cost categories. For
example, bottom-up acquired mental health care costs were
58% higher than top-down acquired mental health care
costs. Furthermore, 23% of the total costs using a top-down
approach were attributed to hospital care, whereas no
hospital care costs were found using the bottom-up
approach. Hence, convergent validity on total direct health
care costs were quite comparable, while the specific cost
categories differed between bottom-up and the top-down
approach. These findings suggest that children, who are not
yet referred for mental health care, might consume more
medical hospital care compared to children who are referred
for mental health care. Therefore, from a cost-of-illness
perspective, it would also be interesting to investigate costs
of families with children with anxiety disorders who are not
referred for mental health treatment, using the cost dairy
developed for this study. It might well be that these families
have more medical health care costs, as the comparison
with top-down acquired data suggests.
This study has some limitations, which should be
addressed. The first limitation is that the low and high
multiplication factor used in this study caused a broad range
of the societal costs of illness. This can be explained by the
broad range of internationally reported prevalence rates and
percentages of children seeking treatment due to differences
in measurements, populations, and criteria that need to be
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appropriate prevalence rate is 9.7% (Verhulst et al. 1997),
which was obtained through the use of a reliable structured
diagnostic interview. The same is true for the 3.5% of
children with mental disorders seeking treatment (Verhulst
and van der Ende 1997). Besides, 4% of the Dutch people
with anxiety disorders are referred for further treatment by
their general practitioner (van Wieren et al. 2007).
Therefore, the prevalence and referral rates used in this
study seem reliable.
The second limitation of the current study is that it can be
argued that 2-week cost diaries filled in by parents are not
representative enough to reliably assess 1-year bottom-up
costs due to the limited time period. However, Goossens et
al. (2000) have found that keeping a diary in a limited period
namely 1 week every month, 2 weeks every 2 months or an
entire year resulted in similar outcomes in fibromyalgia and
pain patients. Another study of Bruijnzeels et al. (1998b)
found that there was a substantial agreement between a
3-week cost diary, filled in by parents, and medical records
concerning general practitioner visits of children. Moreover,
the inclusion period of this study lasted 2 years in which the
cost diaries were filled out, therefore possible seasonal
influences are ruled out. However, it is likely that service
use patterns may vary over the year and do not follow a
stable trajectory. So, for some families the 2-weeks period
for collecting costs may have led to an underestimation of
the total annual costs, whereas for other families this may
have led to an overestimation of the total annual costs.
Nevertheless, as the mean annual costs are based on cost data
from each of these families, it is expected that possible over-
and underestimations of annual costs are balanced.
The third, and most serious, limitation of this study is
that although total health care costs obtained with the top-
down and bottom-up method seemed quite comparable, the
sample of children with a primary diagnosis of anxiety
disorder used in the top-down study by Polder et al. (2002)
might not be fully comparable to the clinically anxious
children from our bottom-up approach in at least three
respects. First, the children in the bottom-up sample were
clinically anxious children with severe anxiety disorders.
The mean number of anxiety disorders was 3 and the mean
severity level 7, indicating severe interference with daily
functioning. The children with a primary diagnosis of
anxiety disorder in the top-down sample might suffer from
different levels of anxiety disorders; some may have minor
anxiety problems, while others may have severe anxiety
problems. This kind of information was not available using
the top-down data. Second, while the clinically anxious
children in the bottom-up sample were awaiting CBT in a
community mental health care setting, the anxious children
in the top-down sample might be in different types and/or
phases of treatment. Again, this kind of information was
not available using the top-down data. Third, the clinically
anxious children in the bottom-up sample were diagnosed
using a universally used semi-structured interview, the
ADIS which is based on DSM-IV criteria (American
Psychiatric Association 1994). In the top-down sample,
children were diagnosed by the doctor in attendance, who
attributed the anxiety diagnosis to the patient based on the
ICD-9 code, without a structured interview. Due to the
classification method, the top-down estimation is possibly
less reliable than the bottom-up cost estimation. Therefore,
results of the comparison between top-down and bottom-up
costs should be interpreted with caution.
In conclusion, this cost-of-illness study shows that the
societal costs of families with a clinically anxious child
who seek treatment amount to more than 20 million euros a
year in the Dutch population, and were 21 times higher than
in families of the general population. An effective treatment
could decrease these costs on the long term. A recent cost-
effectiveness study on family CBT versus individual CBT
showed that societal costs in families with a clinically
anxious child increased during treatment (due to total costs
of 12 sessions CBT a €1,612) but decreased directly after
treatment to baseline level. Even more, during the 1-year
follow-up societal costs dropped below the costs at baseline
(Bodden et al. submitted for publication). Since anxiety
disorders tend to last into adulthood (Newman et al. 1996),
societal costs are likely to be higher at the long term. This
results in anxiety disorders accounting for the highest costs
of all mental illnesses in adulthood in the USA (Dupont et
al. 1996). Hence, societal costs in adults with anxiety
disorders may be saved by providing effective treatments to
children with clinical anxiety disorders.
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